Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 6Brain Neoplasms 5Oligodendroglioma 2Astrocytoma 2Recurrence 1Optic Nerve Glioma 1Gliosarcoma 1Glioma 1Ependymoma 1

Interventions

Carboplatin 8Filgrastim 6Temozolomide 5Etoposide 5etoposide phosphate 3Vincristine 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Melphalan 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Cyproheptadine 2Cyclophosphamide 2Busulfan 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2trioctyl phosphine oxide 1sodium thiosulfate 1sargramostim 1gallium Ga 68 dotatate 1fluorodopa F 18 1antineoplaston AS 2-1 1antineoplaston A10 1Transplantation 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Photochemotherapy 1Perfusion Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Optic Nerve Glioma × Perfusion Magnetic Resonance Imaging × Clear all
NCT02372409 2024-11-01

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Washington University School of Medicine

Phase 2 Terminated
6 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡